KDM1A and acute myeloid leukemia: Interestingly, LSD1 inhibitors promote differentiation of MLL AML cells through disruption of the LSD1/CoREST complex with GFI1 on chromatin; the demethylase activity of LSD1 is not required to sustain the clonogenic activity of leukaemia cells [9].